Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Beaulieu Av Certificates | BEAB | Dec 24, 2024 | 1.19 | 0.00 |
Befimmo SA | BEFB | Dec 24, 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | Dec 24, 2024 | 4 246.05 | +0.54 |
Belreca - Belgian Resources and Capital Company | BELR | Dec 24, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | Dec 24, 2024 | 1.50 | 0.00 |
Belysse Group N.V. | BELYS | Dec 24, 2024 | 0.64 | +1.59 |
Biocartis Group NV | BCART | Dec 24, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Dec 24, 2024 | 0.01 | -6.56 |
Biotalys | BTLS | Dec 24, 2024 | 3.12 | +0.65 |
Boeing | BOEI | Dec 24, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Dec 24, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Dec 24, 2024 | 1.93 | +0.31 |
Brederode S.A. | BREB | Dec 24, 2024 | 108.80 | +1.12 |
Campine nv | CAMB | Dec 24, 2024 | 120.00 | +0.84 |
Candela Invest | CAND | Dec 24, 2024 | 1.20 | 0.00 |
Care Property Invest NV/SA | CPINV | Dec 24, 2024 | 11.22 | +0.36 |
Celyad Oncology SA | CYAD | Dec 24, 2024 | 0.73 | +1.39 |
Cenergy Holdings | CENER | Dec 24, 2024 | 9.20 | -0.76 |
Cofinimmo | COFB | Dec 24, 2024 | 55.00 | +0.92 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Dec 24, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Dec 24, 2024 | 35.74 | +0.90 |
Compagnie du Bois Sauvage S.A. | COMB | Dec 24, 2024 | 220.00 | +2.33 |
Compagnie d`Entreprises CFE SA | CFEB | Dec 24, 2024 | 5.76 | -1.54 |
Crescent NV | OPTI | Dec 24, 2024 | 0.01 | -1.96 |
Cumulex NV | CLEX | Dec 24, 2024 | 0.54 | 0.00 |
Deceuninck NV. | DECB | Dec 24, 2024 | 2.34 | -0.64 |
Deme Group N.V. | DEME | Dec 24, 2024 | 137.00 | +1.03 |
Diegem KennedyCert | DIEG | Dec 24, 2024 | 105.00 | 0.00 |
Distri Land Le Certificat Foncier | DISL | Dec 24, 2024 | 191.00 | 0.00 |
DMS Imaging SA | DMSIM | Dec 24, 2024 | 0.02 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.